RAUVAL Drug Patent Profile
When do Rauval patents expire, and what generic alternatives are available?
Rauval is a drug marketed by Pal Pak and is included in one NDA.
The generic ingredient in RAUVAL is rauwolfia serpentina root. There is one drug master file entry for this compound. Additional details are available on the rauwolfia serpentina root profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for RAUVAL?
- What are the global sales for RAUVAL?
- What is Average Wholesale Price for RAUVAL?
Summary for RAUVAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | RAUVAL at DailyMed |
US Patents and Regulatory Information for RAUVAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pal Pak | RAUVAL | rauwolfia serpentina root | TABLET;ORAL | 009108-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pal Pak | RAUVAL | rauwolfia serpentina root | TABLET;ORAL | 009108-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
